AAES Resident/Fellow Podium & Poster Competition Winners

The AAES Resident/Fellow Podium Competition was established in 1990 to encourage interest in endocrine surgery by those training as students and residents or fellows in general surgery. Presented work may be honored in either the Clinical or Basic Research categories. The AAES Poster Competition was established in 2007.

2024

Rajam Raghunathan, MD - New York University, Grossman School of Medicine
"Can Large Language Models Address Unmet Patient Information Needs and Reduce Provider Burnout in the Management of Thyroid Disease?"

Christopher Carnabatu, MD - UT Southwestern
"Avoidable Biopsies? Validating computer-aided diagnosis (CAD) software in indeterminate thyroid nodules"

INTERESTING CASE: Patty Lu, MD - Mayo Clinic Arizona
"Crashing and Cracking"

POSTER: Jordan Broekhuis, MD - Beth Israel Deaconess Medical Center
"An Assessment of Risk Factors for Bankruptcy Among Thyroid Cancer Patients in Massachusetts"

POSTER: Daniel Chopyk, MD, PhD - The Ohio State University
"Single-nuclei RNA sequencing of Adrenocortical Carcinoma Identifies Replication Stress and ATR Dependency"

2023

Omair Shariq, MD - Mayo Clinic
"Primary Hyperparathyroidism in Patients with Multiple Endocrine Neoplasia Type 1: Impact of Genotype and Surgical Approach on Long-term Postoperative Outcomes"

Grayson Gimblet, BS - University of Alabama at Birmingham
"Thyroid Stimulating Hormone (TSH) Receptor as a Target for Imaging of Thyroid Cancer"

HEALTHER EQUITY: Maeve Alterio, BS - WSU Elson S. Floyd College of Medicine
"Who Serves Where: A Geospatial Analysis of Access to Endocrine Surgeons in the United States and Puerto Rico"

POSTER: Alexis Antunez, MD, MS - Brigham and Women's Hospital
"Cancer-related Fear and Worry in Patients with Low-Risk Thyroid Cancer: A Longitudinal Study"

POSTER: Rachael Guenter, PhD - University of Alabama at Birmingham
"Understanding Transcriptional Regulation of Notch3 Signaling in Pancreatic Neuroendocrine Tumor Cells"

2022

Reid McCallister, MS – University of Michigan
"Multi-genomic analysis of 243 adrenocortical cancer patient tumors identifies a novel microRNA biomarker target (miRNA 335-5p) strongly associated with poor survival"

Kristen Limbach, MD – City of Hope
"Baicalein activates AMPK, inhibits the mammalian target of rapamycin, and exhibits antiproliferative effects in pancreatic neuroendocrine tumors in vitro and in vivo"

POSTER: Omair Shariq, MD – University of Oxford
"Epigenetic Targeting of Bromodomain and Extra-Terminal Domain Proteins as a Novel Therapy for Pancreatic Neuroendocrine Tumors"

POSTER: Sara Ginzberg, MD – University of Pennsylvania
"Disparities in Appropriate Thyroid Cancer Treatment, Before and After the Release of the 2015 American Thyroid Association Guidelines"

2021

Bixiao Zhao, MD - Brigham and Women's Hospital
"Glycolytic Inhibition with 3-Bromopyruvate Suppresses Tumor Growth and Improves Survival in a Murine Model of Anaplastic Thyroid Cancer"

Omair Shariq, MD - Mayo Clinic/University of Oxford
"Clinical Features, Genotype-Phenotype Correctlations, and Treatment Outcomes in Children and Adolescents with Multiple Endocrine Neoplasia Type 1: An International Cohort Study"

POSTER: Nasim Babazadeh, MD - Cleveland Clinic
"The Impact of Thyroid Nodule Afirma Xpression Atlas Results on Clinical Decision-Making"

POSTER: Ujas Shah, MD - University of Pittsburgh Medical Center
"How and When Multiglandular Disease Diagnosed in Sporadic Primary Hyperparathyroidism?"

2020

No competition was held in 2020. The Annual Meeting was cancelled due to the COVID-19 pandemic.

2019

Ton Wang, MD – University of Michigan
“A novel heat shock protein 90 inhibitor potently targets adrenocortical carcinoma tumor suppression via alteration of long non-coding RNA expression”

Amin Madani, MD – Columbia University
“Defining the Competencies for Laparoscopic Transabdominal Adrenalectomy: An Investigation of Intra-Operative Behaviors and Decisions of Experts”

POSTER: Frances T. Lee, MD – Northwestern University
“An Effective Tolerance Approach for Porcine islet Xenotransplantation in Humanized Mice”

POSTER: Wessel MCM Vorselaars, MD, PhD – University Medical Center Utrecht
“Geographic Validation of the Aldosteronoma Resolution Score”

2018

John Tierney, MD – Rush University Medical Center
“Expression of Programmed Death Ligand-1 and 2 in Adrenocortical Cancer Tissues: An exploratory study”

Kristen Limbach, MD – Oregon Health & Science University
“Prospective Study of the Pathophysiology of Carcinoid Crisis”

POSTER: Sarah Fisher, MD – MD Anderson Cancer Center
“Genetic characterization of childhood survivors of the Chernobyl accident with medullary Thyroid cancer”

POSTER: Wessel Vorselaars, MD, PhD – University Medical Center Utrecht
“Clinical outcomes after unilateral adrenalectomy for primary hyperaldoateronism - a large worldwide and recently operated cohort of 435 patients”

2017

Kendall J. Keck – University of Iowa Carver College of Medicine

“Gene expression changes in small bowel neuroendocrine tumors associated with progression to metastases”

Omair Shariq – Mayo Clinic
“Contralateral suppression of aldosterone at adrenal venous Sampling predicts hyperkalemia following adrenalectomy for primary Aldosteronism”

POSTER: Priya Dedhia – University of Michigan
“Human intestinal tissue generates functional insulin producing cells”

POSTER: Heather Wachtel – Massachusetts General Hospital
“A multi-institutional analysis of adrenalectomy for secondary malignancy”

2016

Bruna Babic – National Institute of Health, National Cancer Institute

“Pediatric Patients with Pheochromocytoma and Paragangliomas Should Have Routine Preoperative Genetic Testing for Common Susceptibility Genes and Imaging to Detect Extra-Adrenal and Metastatic Tumors”

Peter T. White – University of Michigan
“A Novel Heat Shock Protein 90 Inhibitor Overcomes Receptor Tyrosine Kinase Resistance in Differentiated Thyroid Cancer”

POSTER: Selena Brouwer – University Medical Center Urecht

“Intratumoral Heterogeneity of Microrna Expression is a Pervasive Feature in Papillary Thyroid Carcinoma”

POSTER: Wouter Kluijfhout – University of California San Francisco
“CEA Should Not Routinely be Used for Detection of a First Recurrence in Patients With MTC”

2015

Diana I. Ortiz – Medical College of Wisconsin
“Cosyntropin Stimulation Testing On Postoperative Day 1 Allows for Selective Glucocorticoid Replacement Therapy in Patients Undergoing Adrenalectomy for Hypercortisolism: Results of a Novel, Multidisciplinary-Derived Institutional Protocolb”

Melanie A. McWade – Vanderbilt University

“Fluorescence Detection of the Parathyroid Gland: Realizing the Potential for Intraoperative Guidance”

POSTER: Idit Dotan – McGill University Health Center
“Bio-Conjugated Nanotechnology to Target Papillary Thyroid Cancer in Vitro” POSTER: Uma Rajhbeharrysingh – Oregon Health and Science University “Ionized Calcium And The Utility Of Maxpth To Evaluate Gastric Bypass Patients and Others With Non-Renal Secondary Hyperparathyroidism”

2014

Heather Wachtel — Philadelphia, Pennsylvania
“Long-term Blood Pressure Control in Patients Undergoing Adrenalectomy for Primary Hyperaldosteronism”

Jessica Maxwell — Iowa City, Iowa

“A Practical Method to Determine the Site of Unknown Primary in Metastatic Neuroendocrine Tumors”

POSTER: Ben James — Chicago, Illinois
“A Novel Ultra-Rapid PTH Assay to Distinguish Parathyroid from Non-Parathyroid Tissue”

2013

Kai-Pun Wong — Hong Kong
“A Prospective Evaluation of Surgeon-Performed Transcutaneous Laryngeal Ultrasonography in Assessing Vocal Cord Function Before and After Thyroidectomy”

Scott K. Sherman — Iowa City, Iowa

“Gastric Inhibitory Polypeptide Receptor: A Future Alternative to Somatostatin Type 2 Receptor Imaging and Treatment in Neuroendocrine Tumors?”

POSTER: Sara Murray — Madison, Wisconsin
“Timing of Symptom Improvement After Parathyroidectomy”

2012

Ashley K. Cayo — Milwaukee, Wisconsin
“Predicting the Need for Calcium and Calcitriol Supplementation After Total Thyroidectomy: Results of a Prospective, Randomized Study”

Thomas J. Quinn — Bronx, New York
“Pasireotide (Som230) Is Effective for the Treatment of Pancreatic Neuroendocrine Tumors in a Multiple Endocrine Neoplasia Type 1 Conditional Knockout Mouse Model”

POSTER: Kevin Shepet — Madison, Wisconsin
“Parathyroid Cryopreservation Following Parathyroidectomy: A Worthwhile Practice?”

2011

Paxton V. Dickson — Houston, Texas
“Achieving Eugastrinemia in MEN1 Patients: Both Duodenal Inspection and Formal Lymph Node Dissection are Important”

Matthew Nehs — Boston, Massachusetts

“Necroptosis is a Novel Mechanism of Radiation-Induced Cell Death in Anaplastic Thyroid Cancer and Adrenocortical Cancer”

POSTER: Luc G.T. Moris — New York, New York
“Rising Incidence of Second Primary Cancer in Low-Risk Patients Receiving Radioactive Iodine Therapy”

2010

David T. Hughes — Ann Arbor, Michigan
“Routine Central Lymph Node Dissection For Papillary Thyroid Cancer”

Matthew A. Nehs — Boston, Massachusetts

“Thyroidectomy With Neoadjuvant Plx4720 Extends Survival And Decreases Tumor Burden In An Orthotopic Mouse Model Of Anaplastic Thyroid Cancer”

POSTER: Aarti Mathur — Bethesda, Maryland
“Adrenal Venous Sampling in Primary Hyperaldosteronism: Standardizing A Gold Standard”

2009

Insoo Suh — San Francisco, California
“Candidate Germline Alterations Predisposing to Familial Nonmedullary Thyroid Cancer Map to Distinct Loci on Chromosomes 1 and 6”

Susan C. Pitt — Madison, Wisconsin

“Tertiary Hyperparathyroidism: Is Less Than a Subtotal Resection Ever Appropriate? A Study of Long-term Outcomes”

POSTER: Matthew Nehs — Boston, Massachusetts
“Inhibition of B-RAFV600 Oncoprotein Prevents Cell Cycle Progression and Invasion In Vitro and Reduces Tumor Growth and Metastasis in an In Vivo Orthotopic Model of Thyroid Cancer”

POSTER: Bian Wu — Los Angeles, California
“Utilization of Parathyroidectomy in the Elderly: A Population-Based Study”

2008

Elizabeth G. Grubbs — Houston, Texas
“Preoperative Vitamin D (VITD) Replacement Therapy in Primary Hyperparathyroidism (PHPT): Safe But Beneficial?”

Linwah Yip — Pittsburgh, Pennsylvania

“Loss of Heterozygosity of Selected Tumor Suppressor Genes in Parathyroid Carcinoma”

POSTER: Pierre Leyre — Poiters, France
“Does the Risk of Compressive Hematoma After Thyroidectomy Authorize One-Day Surgery?”

2007

Tracy S. Wang — New Haven, Connecticut
“How Many Endocrine Surgeons Do We Need?”

David Yu Greenblatt — Madison, Wisconsin

“Valproic Acid Activates Notch1 Signaling and Inhibits Growth in Medullary Thyroid Cancer Cells”

2006

Kyle Zanocco — Chicago, Illinois
“Cost-Effectiveness Analysis of Minimally Invasive Parathyroidectomy for Asymptomatic Primary Hyperparathyroidism”

Ashley Kappes Cayo — Madison, Wisconsin

“Lithium Ions: A Novel Agent for the Treatment of Pheochromocytomas and Paragangliomas”

2005

Mark Cohen — St. Louis, Missouri
“Long-Term Functionality of Cryopreserved Parathyroid Autografts: A 13-Year Prospective Analysis”

Kepal N. Patel — New York, New York

“MUC1 Plays a Role in Tumor Maintenance in Aggressive Thyroid Carcinomas”

2004

Rebecca S. Sippel — Madison, Wisconsin
“Does Propofol Anesthesia Affect Intra-Operative Parathyroid Hormone Levels During Parathyroidectomy? A Randomized Prospective Trial”

David Finley — New York, New York

“Molecular Analysis of Hürthle Cell Neoplasms by Gene Profiling”

2003

Petra Musholt — Hanover, Germany
“RET Rearrangements in Archival Oxyphilic Thyroid Tumors: New Insights in Tumorigenesis and Classification of Hürthle Cell Carcinoma”

Tina W.F. Yen — Houston, Texas

“Medullary Thyroid Carcinoma: Results of a Standardized Surgical Approach in a Contemporary Series of 79 Consecutive Patients from The University of Texas, M. D. Anderson Cancer Center in Houston”

2002

Rasa Zarnegar — San Francisco, California
“Increasing the Effectiveness of Radioactive Iodine Therapy in the Treatment of Thyroid Cancer Using Trichostatin A (TSA), A Histone Deacetylast (HDAC)”

Denise M. Carneiro — Miami, Florida

“Rapid Insulin Assay for Intraoperative Confirmation of Complete Resection of Insulinomas”

2001

Nestor F. Esnaola — Houston, Texas
“Optimal Treatment Strategy in Patients with Papillary Thyroid Cancer: A Decision Analysis”

Katherine T. Morris — Portland, Oregon

“High Dehydroepiandrosterone-Sulfate Predicts Breast Cancer Progression During New Aromatase Inhibitor Therapy and Stimulates Breast Cancer Cell Growth in Tissue Culture: A Renewed Role for Adrenalectomy”

2000

Electron Kebebew — San Francisco, California

“ID1 Proteins Expressed in Medullary Thyroid Cancer”

1999

Andrew Feldman — Bethesda, Maryland
“Results of Heterotrophic Parathyroid Autotransplantation: A 13-Year Experience”

Alan Dackiw — Houston, Texas

“Screening for MENI Mutations in Patients with Atypical Multiple Endocrine Neoplasia”

1998

Julie Ann Sosa — Baltimore, Maryland
“Cost Implications of the Different Management Strategies for Primary Hyperparathyroidism in the US”

David Litvak — Galveston, Texas

“A Novel Cytotoxic Agent for Human Carcinoid”

1997

Herbert Chen — Baltimore, Maryland
“Implanted Programmable Insulin Pumps: 153 Patient Years of Surgical Experience”

K. Michael Barry — Rochester, Minnesota

“Is Familial Hyperparathyroidism a Unique Disease”

1996

Jennifer Meko — St. Louis, Missouri
“Evaluation of Somatostatin Receptor Scintigraphy in Detecting Neuroendocrine Tumors”

Beth A. Ditkoff — New York, New York

“Detection of Circulating Thyroid Cells in Peripheral Blood”

1992

Rodney Pommier — New York, New York

“Eleven Year Experience with Adrenocortical Carcinoma”

1990

Michael J. Demeure — San Francisco, California
“Actin Architecture of Cultured Human Thyroid Cancer Cells: Predictor of Differentiation?”

Gerard M. Doherty — Bethesda, Maryland

“Time to Recovery of the Hypothalamic-Pituitary-Adrenal Axis After Curative Resection of Adrenal Tumors in Patients with Cushing’s Syndrome”